Japan's health ministry said Friday it was probing claims falsified data was used in an Alzheimer's disease study involving major pharmaceutical firms, a day after filing an unrelated criminal complaint against Swiss drugs giant Novartis.
WASHINGTON (Reuters) - Regulators will ask outside experts if the higher of two proposed doses of a Novartis AG drug is needed to treat chronic obstructive pulmonary disease, documents released on Friday said.
